• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.

作者信息

O'Leary J F, Fairclough D L, Jankowski M K, Weeks J C

机构信息

Division of Cancer Epidemiology and Control, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

出版信息

Med Decis Making. 1995 Apr-Jun;15(2):132-7. doi: 10.1177/0272989X9501500205.

DOI:10.1177/0272989X9501500205
PMID:7783573
Abstract

Because they are easy to administer, rating scales are often used as proxies for utility measures. The authors investigated the relationship between time-tradeoff utilities and rating scale values in two populations: 124 cancer patients asked to evaluate their current states of health and 102 relatives and close friends of cancer patients asked to evaluate health-state scenarios. None of the models tested effectively described the relationship between individual patients' rating scale values and time-tradeoff utilities for their current states of health. In contrast, both a plateau and a power-function model explained the variability in the responses of the relatives reasonably well (R2 = 0.56 and R2 = 0.58, respectively). Given that many respondents who were unwilling to trade off any time assigned rating scale values of well below 100, a plateau model may represent the best approach to adjusting rating scale values for health-state scenarios when it is not feasible to elicit time-tradeoff utilities.

摘要

相似文献

1
Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.
Med Decis Making. 1995 Apr-Jun;15(2):132-7. doi: 10.1177/0272989X9501500205.
2
More evidence of the plateau effect: a social perspective.高原效应的更多证据:社会视角
Med Decis Making. 1998 Jul-Sep;18(3):287-94. doi: 10.1177/0272989X9801800306.
3
Stability of time-tradeoff utilities in survivors of myocardial infarction.
Med Decis Making. 1993 Apr-Jun;13(2):161-5. doi: 10.1177/0272989X9301300210.
4
Comparison of Rating Scale, Time Tradeoff, and Conjoint Analysis Methods for Assessment of Preferences in Prostate Cancer.比较前列腺癌偏好评估中评分量表、时间权衡和联合分析方法。
Med Decis Making. 2019 Oct;39(7):816-826. doi: 10.1177/0272989X19873667. Epub 2019 Sep 26.
5
Patient utilities in fibromyalgia and the association with other outcome measures.纤维肌痛患者的效用及其与其他结局指标的关联。
J Rheumatol. 1995 Aug;22(8):1536-43.
6
Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).基于偏好的慢性肌肉骨骼疾病(MSKDs)患儿健康相关生活质量(HRQL)测量
Med Decis Making. 2003 Jul-Aug;23(4):314-22. doi: 10.1177/0272989X03256008.
7
Assessing the performance of utility techniques in the absence of a gold standard.
Med Care. 1999 Jun;37(6):580-8. doi: 10.1097/00005650-199906000-00007.
8
The relationship between health-state utilities and the SF-12 in a general population.普通人群中健康状态效用值与SF-12量表的关系。
Med Decis Making. 1999 Apr-Jun;19(2):128-40. doi: 10.1177/0272989X9901900203.
9
The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication.
Med Decis Making. 1996 Jul-Sep;16(3):217-25. doi: 10.1177/0272989X9601600305.
10
Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.从癌症特异性生活质量问卷中得出基于患者的效用指数。
Value Health. 2009 Jul-Aug;12(5):800-7. doi: 10.1111/j.1524-4733.2009.00505.x.

引用本文的文献

1
Outcome measures for economic evaluations and cost-effectiveness analyses of interventions for people with intellectual disabilities: A methodological systematic review.针对智力残疾者干预措施的经济评估和成本效益分析的结果测量:方法学系统评价。
J Appl Res Intellect Disabil. 2023 Mar;36(2):230-240. doi: 10.1111/jar.13056. Epub 2022 Nov 30.
2
Analytical Frameworks and Outcome Measures in Economic Evaluations of Digital Health Interventions: A Methodological Systematic Review.分析框架和结果衡量在数字健康干预措施的经济评估中的应用:方法学系统综述。
Med Decis Making. 2023 Jan;43(1):125-138. doi: 10.1177/0272989X221132741. Epub 2022 Oct 19.
3
Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis.
与继发性甲状旁腺功能亢进和需要透析的慢性肾病背景下的主要临床事件相关的健康状态效用值。
Health Qual Life Outcomes. 2015 Jun 30;13:90. doi: 10.1186/s12955-015-0266-9.
4
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.评估炎症性肠病患者对治疗方案和护理过程的偏好:定量数据分析的批判性回顾。
Patient. 2013;6(4):241-55. doi: 10.1007/s40271-013-0031-2.
5
Using QALYs in cancer: a review of the methodological limitations.使用 QALYs 评估癌症:方法学局限性的综述。
Pharmacoeconomics. 2011 Aug;29(8):673-85. doi: 10.2165/11588250-000000000-00000.
6
Quality-of-life assessment of fibroid treatment options and outcomes.子宫肌瘤治疗方法及效果的生活质量评估。
Radiology. 2011 Jun;259(3):785-92. doi: 10.1148/radiol.11100704. Epub 2011 Mar 1.
7
A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema.一项前瞻性队列研究使用时间权衡和欧洲五维健康量表(EQ-5D)来定义效用,以评估癌症相关淋巴水肿的影响。
Cancer. 2010 Aug 1;116(15):3722-31. doi: 10.1002/cncr.25068.
8
The burden of age-related macular degeneration: a value-based medicine analysis.年龄相关性黄斑变性的负担:基于价值医疗的分析
Trans Am Ophthalmol Soc. 2005;103:173-84; discussion 184-6.
9
QALYs: are they helpful to decision makers?质量调整生命年:它们对决策者有帮助吗?
Pharmacoeconomics. 2006;24(10):947-52. doi: 10.2165/00019053-200624100-00002.
10
Stability of time trade-off utilities for health states associated with the treatment of prostate cancer.与前列腺癌治疗相关健康状态的时间权衡效用的稳定性。
Qual Life Res. 2002 Aug;11(5):405-14. doi: 10.1023/a:1015609126536.